How to Navigate the Life Sciences Funding LandscapeAmy Cotterill2023-11-20T15:47:54+00:00November 6th, 2023|Article, Investment|
Pioneer Group Announces Participation in £2m Investment in 3D Drug Development Innovator ImmuONESteve Jarvis2023-12-13T16:36:28+00:00October 26th, 2023|Investment, News|
Pioneer Group Announces Investment in Bastion TherapeuticsSteve Jarvis2023-09-12T16:27:35+01:00September 12th, 2023|Investment, News|
Intelligent OMICS Ltd in AI-Driven Research Collaboration with JanssenSteve Jarvis2023-09-07T17:09:11+01:00September 7th, 2023|Investment, News|
Pioneer Group Welcomes Horizon DealSteve Jarvis2023-09-08T09:23:24+01:00September 7th, 2023|Investment, News|
How to Scale a Startup: A Guide for Early-Stage Life Science BusinessesAmy Cotterill2023-11-27T17:32:33+00:00August 15th, 2023|Accelerator, Article, Investment|
How Creative Incubation Supports Life Sciences in the UKSteve Jarvis2023-09-04T15:42:25+01:00July 13th, 2023|Accelerator, BioCity Glasgow, Investment, News|
Commercializing the Success of Scottish Life Sciences Will Rely on Scale-up Space and Government DirectionSteve Jarvis2023-09-04T16:18:05+01:00June 14th, 2023|Article, BioCity Glasgow, Edinburgh Technopole, Investment|
Pioneer Group Appointed Delivery Partner for Innovate UK’s Biomedical Catalyst Accelerator ProgrammeAmy Cotterill2023-09-04T16:01:03+01:00May 10th, 2023|Accelerator, News|
Pioneer Group Adds NunaBio to Venture Building ProgrammeSteve Jarvis2023-07-24T13:59:22+01:00April 21st, 2023|Investment, News|
